查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1916227

可吸收聚乳酸材料市場：按產品類型、技術、等級、最終用戶和應用分類 - 全球預測（2026-2032）

Resorbable Polylactic Acid Material Market by Product Type, Technology, Grade, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，可吸收聚乳酸材料市場價值將達到 13.6 億美元，到 2026 年將成長至 14.4 億美元，到 2032 年將達到 19.9 億美元，年複合成長率為 5.54%。

關鍵市場統計數據
基準年 2025 13.6億美元
預計年份：2026年 14.4億美元
預測年份 2032 19.9億美元
複合年成長率 (%) 5.54%

本文簡要介紹了影響可吸收聚乳酸材料的臨床、生產和監管因素及其在先進醫療應用中的作用。

生物可分解聚乳酸材料在聚合物科學與醫療創新領域發揮關鍵作用，其可預測的生物分解特性和廣泛的加工選擇，能夠支援客製化器械結構。臨床應用範圍涵蓋臨時結構支撐到藥物控釋，而該材料的可調控特性使其在需要梯度載荷傳遞和生物相容性吸收的場合極具吸引力。過去十年，立體化學、分​​子量分佈和共聚策略的進步拓展了其性能範圍，同時也使其能夠相容於積層製造（3D列印）和傳統加工製程。

變革性變化正在重塑醫療保健領域可吸收聚乳酸材料的供應鏈、創新流程和臨床應用路徑。

生物可吸收聚乳酸材料領域正經歷變革性的轉變，這主要得益於加工技術的創新、臨床需求的轉變以及供應鏈的策略重組。積層製造和精密擠出技術能夠實現以往難以企及的複雜幾何形狀和多孔結構，從而支持製造具有可控分解速率的個人化植入和支架。同時，聚合物化學的進步以及先進的滅菌技術正在降低器械的差異性，並擴大可吸收材料的安全適應症範圍。

評估 2025 年美國對可吸收聚乳酸的生產和分銷徵收關稅的累積經濟、營運和供應鏈影響。

2025年公佈的關稅政策為依賴單體、特殊聚合物和成品可吸收聚乳酸組件國際分銷的製造商、供應商和醫療設備公司的營運成本會計帶來了新的複雜性。更高的進口關稅和某些聚合物中間體的重新分類正在影響籌資策略，導致到岸成本上升，並促使企業在地採購和關鍵材料的近岸外包。為此，採購部門正在調整其供應商組合，優先考慮地理多樣性、合約柔軟性以及上游原料供應情況的透明度。

可操作的細分洞察，揭示應用、產品類型、技術、最終用戶和等級如何影響開發重點和商業化策略。

這種細分方法為理解材料性能和加工方法的選擇如何在產品生命週期和最終用途需求中創造最大價值提供了一個實用框架。本研究分析了以下應用領域：藥物傳輸（包括植入式和注射裝置）；整形外科器械（包括鋼釘、鋼板和螺絲）；組織工程（包括水凝膠和支架應用）；以及傷口縫合（包括縫合釘和縫線）。研究檢驗了每種應用如何帶來獨特的機械性能、分解特性和監管要求，從而影響聚合物的選擇和加工路線。按產品類型分類，本研究區分了聚乳酸的主要物理形態——纖維、長絲、薄膜和顆粒——並重點介紹了每種形態在下游製造程序和功能性能方面的不同可能性。

美洲、歐洲、中東和非洲以及亞太地區可吸收聚乳酸（PALA）應用及供應韌性的區域趨勢和戰略機會

區域趨勢對採購、監管溝通和臨床試驗規劃的策略選擇有顯著影響。在美洲，接近性大規模臨床網路和強大的醫療設備製造商生態系統有利於從研究到臨床實踐的快速轉化，但相關人員必須認真考慮複雜的監管環境，該環境強調可靠的臨床證據和上市後監測。在歐洲、中東和非洲，監管協調工作和成熟的醫療設備市場為標準化產品的引入創造了機會。同時，新興需求地區鼓勵建立靈活的生產結構和區域夥伴關係，以適應當地的採購通訊協定。

提供有關領先製造商、創新者和策略聯盟的競爭情報，這些企業正在塑造可吸收聚乳酸產品和技術能力的未來。

可吸收聚乳酸領域的競爭格局主要由三種類型構成：從聚合物生產到器械組裝實現垂直整合的製造商；專注於高純度聚合物和先進加工製程的專業供應商；以及開發底層加工技術和配方的創新技術提供者。在這些類型中，差異化越來越依賴能否證明材料性能的穩定性、可記錄的分解行為以及符合可追溯性和無菌性監管要求的生產流程。

產業領導者加速創新、降低供應風險和最佳化可吸收聚乳酸臨床路徑的實際優先事項

產業領導者應優先考慮一系列切實可行的舉措，以加速技術應用並減少實用化過程中的阻力。首先，在設計過程早期就應將材料開發與預期的臨床應用案例相匹配，確保聚合物性能、加工方法和滅菌技術均檢驗臨床性能標準。這種領先配對能夠減少臨床證據產生過程中的設計變更週期，並縮短法規核准流程。

透明的調查方法，詳細說明了用於分析可吸收聚乳酸產業趨勢的資料來源、定性和定量方法以及檢驗方法。

本調查方法結合了對同行評審文獻的系統性回顧、監管指導文件的分析以及對材料科學、醫療設備工程、臨床實踐和供應鏈管理領域專家的定性訪談。主要研究包括對研發總監、品質和法規專家以及採購負責人進行結構化訪談，以了解影響研發和商業策略的實際限制因素和決策標準。二級資訊來源包括技術文獻、標準機構指南和公開的監管文件，以對材料特性、加工行為和已記錄的臨床結果進行三角驗證。

對相關人員的策略需求進行關鍵性綜合分析，以協調材料創新和監管路徑，從而加速可吸收聚乳酸的臨床應用。

這項綜合分析著重指出了相關人員在尋求利用可吸收聚乳酸材料潛力時面臨的三大相互關聯的關鍵挑戰：技術嚴謹性、供應鏈韌性和監管完整性。技術嚴謹性意味著建立可重複的聚合物性能和加工通訊協定，從而轉化為可預測的體內性能。這需要對分析表徵、分解曲線分析和製程控制進行投入，並且這些工作必須儘早記錄並持續到規模化生產過程中。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 可吸收聚乳酸材料市場（依產品類型分類）

  • 纖維
  • 燈絲
  • 電影
  • 顆粒

9. 依技術分類的可吸收聚乳酸材料市場

  • 3D列印
  • 擠壓
  • 射出成型
  • 溶劑澆鑄

第10章 可吸收聚乳酸材料市場（依等級分類）

  • 醫用級
  • 醫藥級

第11章 可吸收聚乳酸材料市場（以最終用戶分類）

  • 診所
  • 醫院
  • 製藥公司
  • 研究所

第12章 可吸收聚乳酸材料市場（依應用領域分類）

  • 藥物輸送
    • 植入式醫療器材
    • 注射裝置
  • 整形外科器械
    • 別針
    • 盤子
    • 擰緊
  • 組織工程
    • 水凝膠
    • 鷹架
  • 傷口縫合
    • 史泰博
    • 縫合線

第13章 可吸收聚乳酸材料市場（依地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 可吸收聚乳酸材料市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國可吸收聚乳酸材料市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國可吸收聚乳酸材料市場

第17章 中國吸水性聚乳酸材料市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Chongqing Jindan Bio-Technology Co., Ltd.
  • Corbion NV
  • Evonik Industries AG
  • FKuR Kunststoff GmbH
  • Mitsui Chemicals, Inc.
  • NatureWorks LLC
  • Shenzhen Esun Industrial Co., Ltd.
  • Synbra Technology NV
  • TotalEnergies Corbion BV
  • Unitika Ltd.
  • Zhejiang Hisun Biomaterials Co., Ltd.
Product Code: MRR-AE420CB15319

The Resorbable Polylactic Acid Material Market was valued at USD 1.36 billion in 2025 and is projected to grow to USD 1.44 billion in 2026, with a CAGR of 5.54%, reaching USD 1.99 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.36 billion
Estimated Year [2026] USD 1.44 billion
Forecast Year [2032] USD 1.99 billion
CAGR (%) 5.54%

A concise introduction to clinical, manufacturing, and regulatory forces shaping resorbable polylactic acid materials and their role in advanced medical applications

Resorbable polylactic acid materials occupy a pivotal role at the intersection of polymer science and medical innovation, offering predictable biodegradation profiles and a broad suite of processing options that support bespoke device architectures. Clinical applications span temporary structural support to controlled drug release, and the material's tunable properties make it attractive where gradual load transfer and biocompatible resorption are required. Over the past decade, advances in stereochemistry control, molecular weight distribution, and copolymerization strategies have expanded performance envelopes while enabling compatibility with additive manufacturing and conventional processing routes.

Manufacturers and clinical developers must navigate a layered regulatory environment where biocompatibility data, sterilization compatibility, and traceability are core requirements. Concurrently, supply chain considerations extend from monomer sourcing to polymerization capacity and post-processing capabilities, shaping how quickly novel PLA-based solutions progress from bench to bedside. These converging forces underscore the importance of a cohesive strategy that aligns material selection with device design intent, clinical evidence generation, and scalable manufacturing approaches.

This introduction frames the subsequent analysis by emphasizing the dual imperatives of technical robustness and regulatory readiness. By positioning material attributes alongside manufacturing realities and clinical needs, stakeholders can prioritize investments and collaborations that reduce translational risk and accelerate adoption in targeted therapeutic areas.

Transformative shifts redefining supply chains, innovation pipelines, and clinical adoption pathways for resorbable polylactic acid materials across healthcare sectors

The landscape for resorbable polylactic acid materials is undergoing transformative shifts driven by innovation in processing technologies, evolving clinical expectations, and strategic reconfiguration of supply chains. Additive manufacturing and precision extrusion are enabling complex geometries and porous architectures that were previously infeasible, supporting more personalized implants and scaffold constructs with controlled degradation kinetics. Simultaneously, the convergence of polymer chemistry improvements and advanced sterilization techniques is reducing device variability and broadening indications where resorbable materials can safely perform.

On the clinical front, practitioners are increasingly seeking implants and wound closure systems that reduce the need for secondary procedures and minimize long-term foreign body presence. This clinical demand is catalyzing collaboration between material scientists, device engineers, and clinicians to co-design solutions validated through robust preclinical models and targeted clinical studies. From a commercial perspective, firms are reassessing vertical integration versus specialized partnerships to optimize cost, agility, and intellectual property capture across the value chain.

These shifts occur alongside heightened regulatory scrutiny around safety and traceability, prompting manufacturers to embed comprehensive biocompatibility and degradation profiling into early development stages. As a result, the adoption curve for next-generation PLA materials will depend on how quickly organizations can translate laboratory-level material performance into documented clinical reliability and scalable manufacturing processes. Stakeholders that anticipate these shifts and invest in cross-disciplinary teams will be better positioned to set technical standards and capture clinical trust.

Assessing the cumulative economic, operational, and supply chain impact of United States tariffs implemented in 2025 on resorbable polylactic acid production and distribution

The tariff measures announced in 2025 introduced a new layer of complexity to the operational calculus for manufacturers, suppliers, and device makers relying on transnational flows of monomers, specialty polymers, and finished resorbable polylactic acid components. Increased import duties and reclassification of certain polymer intermediates have impacted procurement strategies by elevating landed costs and incentivizing local sourcing or nearshoring of critical inputs. In response, procurement teams are recalibrating supplier portfolios to prioritize geographic diversification, contractual flexibility, and visibility into upstream raw material availability.

Operationally, tariff-related friction has accelerated interest in alternate manufacturing footprints and reshoring initiatives that reduce exposure to cross-border policy volatility. Companies are evaluating whether investments in local polymerization capacity, strategic stockpiling, or supplier alliances can offset the unpredictability introduced by trade measures. This reevaluation often aligns with parallel efforts to shorten lead times and establish regional quality control hubs that support faster product iterations and regulatory submissions.

Importantly, tariff effects extend beyond direct cost increases. They influence decisions on where to site final device assembly, where to conduct additively manufactured production runs, and how to structure contractual clauses related to cost pass-through and supply continuity. For many stakeholders, the cumulative impact of tariff changes in 2025 has been a catalyst to adopt more resilient and responsive supply chain architectures, integrate scenario planning into procurement, and negotiate longer-term strategic partnerships that can withstand policy-induced disruptions.

Actionable segmentation insights revealing how applications, product types, technologies, end users, and grades influence development priorities and commercialization strategies

Segmentation offers a practical framework to understand where material attributes and processing choices deliver the most value across product life cycles and end-use demands. Based on Application, the study examines Drug Delivery with its implantable devices and injectable devices, Orthopedic Devices with its pins, plates, and screws, Tissue Engineering with hydrogel and scaffold applications, and Wound Closure with staples and sutures; examining how each application imposes unique mechanical, degradation, and regulatory requirements that influence polymer selection and processing pathways. Product Type distinctions between fiber, filament, film, and pellet delineate the primary physical forms through which polylactic acid is handled, with each form presenting different opportunities for downstream manufacturing and functional performance.

Based on Technology, the analysis compares 3D printing, extrusion, injection molding, and solvent casting to reveal how processing capability shapes design freedom, tolerances, and scalability. For example, additive manufacturing enables architected porosity and patient-specific geometries, whereas injection molding and extrusion offer high-throughput production suited to standardized components. Based on End User, the study considers clinics, hospitals, pharmaceutical companies, and research institutes to understand the varying procurement cycles, quality expectations, and clinical evidence needs that purchasers impose on suppliers. Finally, Based on Grade, the differentiation between medical grade and pharmaceutical grade polymers underscores distinctions in purity requirements, documentation, and suitability for drug-contact versus structural applications.

Integrating these segmentation lenses reveals nuanced opportunity spaces: certain applications favor high-throughput pellet- and extrusion-based supply chains, while others demand filament or fiber forms paired with additive manufacturing to realize customization and complex functionalization. End users with accelerated clinical adoption pathways, such as specialized clinics or research institutes, can act as early adopters for novel device concepts, whereas hospitals and pharmaceutical companies often require more extensive validation and standardized production processes. Grade selection remains a gating factor for regulatory acceptance and product claims, making early investment in high-purity feedstock and traceable supply chains a common strategic priority.

Regional dynamics and strategic opportunities across the Americas, Europe Middle East and Africa, and Asia-Pacific for resorbable polylactic acid adoption and supply resilience

Regional dynamics materially affect strategic choices across sourcing, regulatory engagement, and clinical trial planning. In the Americas, proximity to large clinical networks and a strong ecosystem of device manufacturers supports rapid translation from bench to bedside, but stakeholders must navigate a complex reimbursement and regulatory landscape that places a premium on robust clinical evidence and post-market surveillance. In Europe Middle East & Africa, regulatory harmonization initiatives and mature medical device markets create opportunities for standardized product introductions, while pockets of emerging demand incentivize flexible manufacturing and regional partnerships that can adapt to local procurement protocols.

In the Asia-Pacific region, growth drivers include expanding medical infrastructure, a growing base of local polymer producers, and strong capabilities in additive manufacturing and contract manufacturing services. These regional differences influence choices about where to locate polymerization capacity, quality control centers, and final device assembly. For instance, manufacturing in regions with established polymer intermediates supply chains can reduce lead times for pellets and filaments, whereas regions with advanced clinical research networks may be better suited for early-stage clinical validation of novel constructs.

Taken together, regional strategy should consider not only cost and capacity but also regulatory timelines, reimbursement pathways, and access to specialized clinical expertise. Cross-regional collaboration and tiered product rollouts can allow companies to leverage regional strengths while mitigating the risks associated with regulatory variability and trade policy shifts.

Competitive intelligence on leading manufacturers, innovators, and strategic partnerships shaping the future of resorbable polylactic acid products and capabilities

Competitive dynamics in the resorbable polylactic acid space are shaped by three broad archetypes: vertically integrated manufacturers that control polymer production through device assembly, specialized suppliers focused on high-purity polymer grades and advanced processing forms, and innovative technology providers developing enabling processing technologies and formulations. Across these archetypes, differentiation increasingly hinges on the ability to demonstrate consistent material performance, documented degradation behavior, and manufacturing processes that meet regulatory expectations for traceability and sterility.

Strategic partnerships and licensing arrangements are prevalent as device makers seek to accelerate time-to-market while managing technical risk. Collaborations between polymer producers and additive manufacturing firms enable co-development of feedstocks optimized for specific printing platforms, while alliances with contract manufacturers support scale-up from pilot to commercial volumes. Intellectual property around polymer modification, surface treatments, and controlled-release capabilities can provide defensible competitive advantage, particularly when coupled with clinical evidence that substantiates improved patient outcomes.

Investment patterns point to a focus on process control, quality systems, and regulatory science capabilities. Companies that bolster their regulatory affairs teams and build robust analytical packages for degradation, biocompatibility, and sterilization compatibility are better positioned to secure procurement contracts and clinical adoption. For many organizations, the strategic imperative is to combine material science leadership with manufacturing excellence and targeted clinical partnerships to translate innovation into widely adopted medical solutions.

Practical, prioritized recommendations for industry leaders to accelerate innovation, mitigate supply risks, and optimize clinical adoption pathways for resorbable polylactic acid

Industry leaders should prioritize a set of pragmatic actions to accelerate adoption and reduce translational friction. First, align material development with intended clinical use cases early in the design process to ensure that polymer properties, processing methods, and sterilization approaches are validated against clinical performance criteria. This front-loaded alignment reduces redesign cycles and shortens regulatory pathways when clinical evidence is generated.

Second, diversify supply chains geographically and contractually to reduce exposure to single-source disruptions and trade policy shifts. Establishing regional polymerization or compounding capabilities, combined with rigorous supplier qualification and inventory strategies, can improve resilience without sacrificing quality. Third, invest in modular manufacturing platforms and cross-validated processing protocols that enable rapid shifts between production modes such as extrusion, injection molding, and additive manufacturing; this flexibility supports both customization and scale.

Fourth, cultivate strategic clinical partnerships that provide early-stage evidence of safety and functional performance, leveraging research institutes and specialized clinics as pilot sites while preparing for larger hospital-based studies. Fifth, strengthen regulatory engagement by developing comprehensive degradation, biocompatibility, and traceability data packages and by participating in standards development where possible. Finally, consider strategic IP and licensing approaches that protect core innovations while enabling broader adoption through partnerships and co-development agreements. Executing these recommendations in parallel, with clear accountability and timelines, will increase the probability of successful commercialization and clinical uptake.

Transparent research methodology detailing data sources, qualitative and quantitative techniques, and validation approaches used to analyze resorbable polylactic acid industry dynamics

The research methodology combines systematic review of peer-reviewed literature, analysis of regulatory guidance documents, and qualitative interviews with subject-matter experts across materials science, device engineering, clinical practice, and supply chain management. Primary research included structured interviews with R&D leads, quality and regulatory professionals, and procurement specialists to capture real-world constraints and decision criteria that shape development and commercial strategy. Secondary sources comprised technical publications, standards bodies' guidance, and public regulatory filings to triangulate evidence on material properties, processing behavior, and documented clinical outcomes.

Analytical techniques included cross-sectional synthesis of technological capabilities against application requirements, scenario analysis to evaluate supply chain resilience under policy shifts, and capability mapping to identify gaps between current manufacturing practices and clinical evidence generation needs. Validation was achieved through iterative reviews with industry experts and through comparison of documented case studies that illustrate successful translation pathways. Throughout the research process, emphasis was placed on traceability of sources, reproducibility of analytical steps, and transparency in assumptions so that findings can be interrogated and applied to a range of strategic decisions.

This mixed-methods approach ensures that the conclusions and recommendations are grounded in technical reality, informed by practical constraints, and validated by those working at the interface of material science and clinical application.

Conclusive synthesis of strategic imperatives for stakeholders to align material innovation and regulatory pathways to accelerate clinical integration of resorbable polylactic acid

The synthesis underscores three interrelated imperatives for stakeholders seeking to harness the potential of resorbable polylactic acid materials: technical rigor, supply chain resilience, and regulatory alignment. Technical rigor involves establishing reproducible polymer properties and processing protocols that translate into predictable in vivo performance. This requires investment in analytical characterization, degradation profiling, and process controls that are documented early and maintained through scale-up.

Supply chain resilience means diversifying sources, shortening critical lead times where feasible, and embedding contractual mechanisms that protect against policy and market volatility. Organizations that couple supply-side robustness with adaptive manufacturing capabilities will be better equipped to respond to evolving clinical requirements and to scale production without compromising quality. Regulatory alignment is the connective tissue that ties technical and commercial efforts together; proactive engagement with regulators and participation in standards development can streamline submission pathways and support broader clinical adoption.

Together, these imperatives create a practical framework for converting material science advances into clinically meaningful products. Stakeholders who coordinate investments across these dimensions and maintain a clear line of sight from material properties to patient outcomes will create the strongest foundation for durable competitive advantage.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Resorbable Polylactic Acid Material Market, by Product Type

  • 8.1. Fiber
  • 8.2. Filament
  • 8.3. Film
  • 8.4. Pellet

9. Resorbable Polylactic Acid Material Market, by Technology

  • 9.1. 3D Printing
  • 9.2. Extrusion
  • 9.3. Injection Molding
  • 9.4. Solvent Casting

10. Resorbable Polylactic Acid Material Market, by Grade

  • 10.1. Medical Grade
  • 10.2. Pharmaceutical Grade

11. Resorbable Polylactic Acid Material Market, by End User

  • 11.1. Clinics
  • 11.2. Hospitals
  • 11.3. Pharmaceutical Companies
  • 11.4. Research Institutes

12. Resorbable Polylactic Acid Material Market, by Application

  • 12.1. Drug Delivery
    • 12.1.1. Implantable Devices
    • 12.1.2. Injectable Devices
  • 12.2. Orthopedic Devices
    • 12.2.1. Pins
    • 12.2.2. Plates
    • 12.2.3. Screws
  • 12.3. Tissue Engineering
    • 12.3.1. Hydrogel
    • 12.3.2. Scaffold
  • 12.4. Wound Closure
    • 12.4.1. Staples
    • 12.4.2. Sutures

13. Resorbable Polylactic Acid Material Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Resorbable Polylactic Acid Material Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Resorbable Polylactic Acid Material Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Resorbable Polylactic Acid Material Market

17. China Resorbable Polylactic Acid Material Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Chongqing Jindan Bio-Technology Co., Ltd.
  • 18.6. Corbion N.V.
  • 18.7. Evonik Industries AG
  • 18.8. FKuR Kunststoff GmbH
  • 18.9. Mitsui Chemicals, Inc.
  • 18.10. NatureWorks LLC
  • 18.11. Shenzhen Esun Industrial Co., Ltd.
  • 18.12. Synbra Technology N.V.
  • 18.13. TotalEnergies Corbion B.V.
  • 18.14. Unitika Ltd.
  • 18.15. Zhejiang Hisun Biomaterials Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY GRADE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY FIBER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY FIBER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY FIBER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY FILAMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY FILAMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY FILAMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY FILM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY FILM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY FILM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY PELLET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY PELLET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY PELLET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY 3D PRINTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY 3D PRINTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY 3D PRINTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY EXTRUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY EXTRUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY EXTRUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY INJECTION MOLDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY INJECTION MOLDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY INJECTION MOLDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY SOLVENT CASTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY SOLVENT CASTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY SOLVENT CASTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY MEDICAL GRADE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY MEDICAL GRADE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY MEDICAL GRADE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY PHARMACEUTICAL GRADE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY PHARMACEUTICAL GRADE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY PHARMACEUTICAL GRADE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY DRUG DELIVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY DRUG DELIVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY IMPLANTABLE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY IMPLANTABLE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY IMPLANTABLE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY INJECTABLE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY INJECTABLE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY INJECTABLE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY ORTHOPEDIC DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY ORTHOPEDIC DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY ORTHOPEDIC DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY ORTHOPEDIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY PINS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY PINS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY PINS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY PLATES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY PLATES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY PLATES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY SCREWS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY SCREWS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY SCREWS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TISSUE ENGINEERING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TISSUE ENGINEERING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TISSUE ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY HYDROGEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY HYDROGEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY HYDROGEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY SCAFFOLD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY SCAFFOLD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY SCAFFOLD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY WOUND CLOSURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY WOUND CLOSURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY WOUND CLOSURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY WOUND CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY STAPLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY STAPLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY STAPLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY SUTURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY SUTURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY SUTURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY ORTHOPEDIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TISSUE ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY WOUND CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY ORTHOPEDIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TISSUE ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY WOUND CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY ORTHOPEDIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TISSUE ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY WOUND CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY ORTHOPEDIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TISSUE ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY WOUND CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY ORTHOPEDIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TISSUE ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY WOUND CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY ORTHOPEDIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TISSUE ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY WOUND CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY ORTHOPEDIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TISSUE ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY WOUND CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY ORTHOPEDIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TISSUE ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY WOUND CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. ASEAN RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. ASEAN RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY ORTHOPEDIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TISSUE ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY WOUND CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 184. GCC RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 185. GCC RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. GCC RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 187. GCC RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 188. GCC RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. GCC RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 190. GCC RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 191. GCC RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY ORTHOPEDIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 192. GCC RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TISSUE ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 193. GCC RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY WOUND CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPEAN UNION RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPEAN UNION RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPEAN UNION RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY ORTHOPEDIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TISSUE ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY WOUND CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 204. BRICS RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 205. BRICS RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. BRICS RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 208. BRICS RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 209. BRICS RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 211. BRICS RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY ORTHOPEDIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 212. BRICS RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TISSUE ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY WOUND CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 214. G7 RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 215. G7 RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. G7 RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 217. G7 RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 218. G7 RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. G7 RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 220. G7 RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 221. G7 RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY ORTHOPEDIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 222. G7 RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TISSUE ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 223. G7 RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY WOUND CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 224. NATO RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 225. NATO RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. NATO RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 227. NATO RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 228. NATO RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 229. NATO RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 230. NATO RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 231. NATO RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY ORTHOPEDIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 232. NATO RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TISSUE ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 233. NATO RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY WOUND CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 234. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 235. UNITED STATES RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 236. UNITED STATES RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. UNITED STATES RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED STATES RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 239. UNITED STATES RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 240. UNITED STATES RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED STATES RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 242. UNITED STATES RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY ORTHOPEDIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 243. UNITED STATES RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TISSUE ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED STATES RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY WOUND CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 245. CHINA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 246. CHINA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. CHINA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 248. CHINA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 249. CHINA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 250. CHINA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 251. CHINA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 252. CHINA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY ORTHOPEDIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 253. CHINA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TISSUE ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 254. CHINA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY WOUND CLOSURE, 2018-2032 (USD MILLION)